“But there is almost twice that with tinnitus – 2.7 million veterans – and they have nothing for them,” Dr O’Neill said. He added that, at present, compensation to this group is costing the US about $4.9 billion a year.
The latest funding – which more than doubles the money the NUI Maynooth spin-out has raised since it was founded in 2010 – is split evenly between venture debt funding from the European Investment Bank and new equity investment. The equity investment was led by a new shareholder, Italian life sciences specialist Panakès, but also includes the company’s existing shareholders.
“We have continued to have the complete support of all of our long-term investors and now Panakès has joined that group as well,” said Dr O’Neill.
Ireland Ireland Latest News, Ireland Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Neuromod raises €30m to fund drive into US marketCompany’s Lenire device approved by FDA uses sound and electric stimulation to ease symptoms of tinnitus
Read more »
Neuromod fundraising, office market slump, proxy adviser backs Kingspan’s MurtaghBusiness Today: the best news, analysis and comment from The Irish Times business desk
Read more »